Search Results - Paid Trials

Login to your account

Reset Password

Please Enter Username or Email

Create a free account

I'm a Participant
I'm an Organization

Showing 1 – 20 of 56 results

High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients

by CTG

in Influenza, Immunization; Infection, Transplantation Infection, Solid Organ Transplant

Other

Tennessee

Deadline:

12/31/2026

Functional Impact of Acute Respiratory Viral Infections in Older Adults

by CTG

in Respiratory Infections in Old Age

Other

New York

Deadline:

06/15/2027

Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and Older

by CTG

in Healthy Volunteers, Pandemic Influenza Immunization

Other

California

Deadline:

12/01/2026

A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.

by CTG

in Vascular Dementia, Herpes Zoster (HZ)

Other

Texas

Deadline:

08/01/2030

Pilot Influenza Challenge Study

by CTG

in Influenza

Other

Missouri

Deadline:

06/30/2026

Intranasal LAIV Mucosal Immunity Examination

by CTG

in Impact of Vaccination

Other

Maryland

Deadline:

07/01/2026

COVID-19 Reactogenicity

by CTG

in Compare Post Vaccination Reactions

Other

Oregon

Deadline:

06/30/2028

The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)

by CTG

in Rheumatic Diseases

Other

Alabama

Deadline:

08/01/2026

A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)

by CTG

in Influenza A

Other

California

Deadline:

12/29/2026

Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement

by CTG

in COVID-19

Other

Pennsylvania

Deadline:

12/31/2026

Flu Infection at UPHS

by CTG

in Influenza Human

Other

Pennsylvania

Deadline:

09/30/2026

Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)

by CTG

in COPD

Other

North Carolina

Deadline:

03/01/2026

BPL-1357 Against H1N1 Influenza Virus Challenge

by CTG

in Influenza, Human

Other

Maryland

Deadline:

03/01/2028

Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas

by CTG

in Classical Hodgkin Lymphoma, Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

Other

Texas

Deadline:

06/01/2037

B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults

by CTG

in Influenza

Other

Alabama

Deadline:

05/01/2026

Dissecting Human Immune Responses to Infection with Influenza or SARS-CoV-2

by CTG

in Influenza, SARS-CoV-2 (COVID-19) Infection, Immune Response of Host

Other

Missouri

Deadline:

10/01/2029

Characterizing the Human Airway Immune Response to FluMist Vaccination

by CTG

in Healthy Young Adults, Influenza Vaccines, Influenza Vaccine Response

Other

Missouri

Deadline:

11/01/2028

Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

by CTG

in Pediatric Cancer

Other

North Carolina

Deadline:

10/01/2030

Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination

by CTG

in Influenza, COVID-19

Other

Maryland

Deadline:

12/31/2026

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

by CTG

in Influenza, Human

Other

Alabama

Deadline:

12/01/2026

Load more All clinical trials loaded.